Gene Expression Assays Test Market

The rapidly surging prevalence of breast cancer among the population globally and other major driving factors is expected to favour the rise in the global gene expression assays test market

 

Reports and Insights (R&I) has published a new report titled, “Gene Expression Assays Test Market: Opportunity Analysis and Future Assessment 2020-2028

Global Gene Expression Assays Test Market, By Type (Oncotype DX, MammaPrint, PAM50/Prosigna, EndoPredict, MapQuant Dx, IHC4, Theros-Breast Cancer Gene Expression Ratio Assay), By End-User (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2028.

The global gene expression assays test market in 2020 is estimated for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of xx%.

Gene expression is the procedure of making specialized proteins from the details composed in the genes. As a matter of fact, various tissues show various arrays of genes dependent on their duty in the body. Gene expression tests assess the RNA in an individual’s tissue specimen to ascertain which genes are ardently making proteins.

In the present day and age, the fresh technological advances are favorably making it possible to examine the expression of the whole genome in a sole experiment. These gene expression assays accompany or substitute earlier assays which assessed the gene expression of only one single gene, or a specific bunch of genes. Owing to numerous technological advancements in the field of genomics and continuous research activities for further advancements and innovations is majorly driving the demand of gene expression assay tests across the global market. Thus, the global gene expression assay test market is projected to rise substantially in the years to come.

On top of that, the rapidly growing prevalence of cancer among the population worldwide, particularly breast cancer, is another major factor that is massively contributing to the rising traction of gene expression assay tests across the global market. Attributing to which, the global gene expression assay tests market is estimated to rise significantly in the forthcoming years.

However, shortage of healthcare professionals and expertise in the field of genomics, particularly in emerging economies, is likely to hold back the growth of the global gene expression assays test market in the given timeframe.

Nonetheless, the increasing number of collaborations of established players of the markets with the emerging players of the global markets is yet estimated to positively fuel the growth of the global gene expression assay tests market in the coming years.

R&I Study identifies some of the key participating players in the gene expression assays test market globally are Palex Group, Thermo Fisher Scientific, Exact Sciences UK, Ltd., Medilinks Inc., Genomic Health, Inc., Agendia NV, Veracyte, Inc., NeoGenomics, NanoString, Myriad Genetics, Qiagen, Biogenex, BioTheranostics, Inc., among others.

About Reports and Insights

Reports and Insights (R&I) is committed to providing deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client's needs and regularly ponder how to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us

Reports and Insights (R&I)

Tel: +1-(281)-619-8646

For Sales Query: [email protected]

For New Topics & Other Info: [email protected]





This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK